We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 389

Federal Court of Appeal upholds refusal to expunge trade-mark

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2013

McCallum applied to expunge a trade-mark pursuant to section 57 of the Trade-marks Act. The Court dismissed the Application. The parties agreed that

Trial Judge's findings of anticipation and obviousness upheld on appeal

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2013

This is an appeal of a patent infringement decision. The Court found the patent invalid for anticipation and obviousness. The Court of Appeal held

Other industry news

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 6 2013

The Federal Government has introduced Bill C-56, whose short title is the Combating Counterfeit Products Act. It makes amendments to the Copyright

Plasti-Fab Ltd v. The Attorney General of Canada

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 15 2010

This is an application pursuant to s. 52 of the Patent Act for an Order requiring the Commissioner of Patents to add an inventor to two issued Canadian Patents

Eli Lilly Canada Inc. et al. v. Novopharm Limited

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 15 2010

Lilly commenced an action for patent infringement, and Novopharm, by way of counterclaim, brought an action for damages pursuant to s 8 of the Patented Medicines (Notice of Compliance) Regulations

Canada (Minister of Health) v. Merck Frosst Canada Ltd

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 15 2010

An English translation of a decision relating to two appeals issued in May 2009 was issued by the Court

Apotex Inc. v. Merck Frosst Canada & Co.

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 15 2010

This is an action decided under s 8 of the Patented Medicines (Notice of Compliance) Regulations between Apotex and Merck relating to norfloxacin

Sanofi-aventis Canada Inc. et al. v. Novopharm Limited

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 15 2010

Following an infringement trial, where the patent was found to be invalid, Novopharm’s counterclaim under s 8 of the Patented Medicines (Notice of Compliance) Regulations is going forward

Apotex Inc. v. sanofi-aventis

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 15 2010

Apotex commenced an impeachment action against sanofi-aventis

Other industry happenings of note

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 15 2010

Health Canada published a Guidance for Sponsors: Information and Submission Requirements for Subsequent Entry Biologics (SEBs) and updated the Guidance Documents for Data Protection and the PMNOC Regulations

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy